Studies on mouse and rat EGCs suggest that EGC activation may be involved in IBS-like visceral hypersensitivity independently or synergistically with BDNF, and this process may be triggered via a BDNF-TrkB-associated signaling pathway. Here, BDNF is linked to irritable bowel syndrome.